ABN Newswire

Asian Activities Report for October 11, 2011: Allied Healthcare Group (ASX:AHZ) Report Successful Pre-Clinical Testing of Herpes Simplex Virus 2 Vaccine

newsroom@abnnewswire.net — Tue, 11 Oct 2011 12:00:13 GMT

Allied Healthcare Group (ASX:AHZ) says today that its investee company Coridon Pty Ltd has successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 vaccine with outstanding results. Having achieved this milestone, Coridon has now secured additional funding from its major investor Allied Healthcare Group and plans to commence manufacturing and undertake formal pre-clinical safety studies before testing the vaccine in a Phase I clinical study.

Universal Biosensors, Inc. (ASX:UBI) has commenced a new research and development project for Cilag GmbH International to determine the feasibility of an innovative blood glucose product to be used in the field of diabetes. The feasibility project is expected to take approximately 12 months for which Universal Biosensors will receive US$4.5 million against a series of milestones.

Kalgoorlie Mining Company Limited (ASX:KMC) reports that recent drilling of the East Lode at the Bullant gold mine has intersected a spectacular high grade gold zone of 4.6m at 26.19g/t Au, representing the best drill assay result the Company has achieved at the Bullant gold project since its acquisition in April 2011. Drilling is currently continuing and further extensional drilling is planned. The Company expects to generate rapid shareholder wealth through development, production and exploration of the Bullant Gold Project.

Midas Resources Limited (ASX:MDS) will commence aircore drilling on a gold target south of the Intrepid Prospect at the Company's Lake Carey Project in Western Australia. The Intrepid prospect covers an area of widespread gold anomalism situated in the northwest part of the Lake Carey project. All necessary approvals have been obtained and drilling is to commence later this week.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Asian Activities Report for September 30, 2011: Neon Energy (ASX:NEN) Sixth Well Successfully Brought Onstream in North San Ardo Oil Field, California

newsroom@abnnewswire.net — Fri, 30 Sept 2011 12:00:34 GMT

Neon Energy Limited (ASX:NEN) says today that the recently drilled Lombardi 19-27H development well in the North San Ardo oil field, onshore California, has been brought onstream, with a stabilised initial production rate of approximately 250 bopd. This is the Company's sixth successful acceleration well to date. Total production at the oil field is currently in the range of 650 bopd to 700 bopd, with sales pricing at over US$100 per barrel.

India Resources Limited (ASX:IRL) has signed a A$249M coal operations contract with Prism Cement Limited (BOM:500338) to develop and operate the first phase of Prism's Sial Ghoghri coal mine in India for over 30 years. The first phase of the mine development is expected to produce 9.06 million tonnes of coal.

Guildford Coal Limited (ASX:GUF) has upgraded its Exploration Targets at its Mongolian coal projects to 30Mt to 1.380Bt, comprising Exploration Targets of 0-700Mt at the South Gobi Project and 30Mt-680Mt at the Middle Gobi Project. The Company plans to continue the current drilling program at both Projects with a view to defining JORC compliant resources by the end of October 2011.

Tissue Therapies Limited (ASX:TIS) says today that commercial negotiations are proceeding very well and the Company expects to start the sales of VitroGro(R) for the treatment of chronic wounds in the UK and Europe during the second quarter of 2012. In addition, preparations for the FDA clinical trial of VitroGro(R) for the treatment of venous ulcers are almost complete, and patient recruitment for the trial is planned to start during December 2011.

Biotron Limited (ASX:BIT) has commenced a human trial of its lead HIV drug candidate, BIT225, to further demonstrate its ability to reduce HIV loads in HIV-infected reservoir cells. BIT225 has recorded encouraging data in previous trials in healthy volunteers and Hepatitis C virus-infected patients. The results of the current trial is expected in the first quarter of 2012.

Circadian Technologies Limited (ASX:CIR) has submitted an investigational new drug application to the FDA to initiate clinical studies of VGX-100. The first trial will involve the treatment of a variety of different cancer types in patients with late stage cancer.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Asian Activities Report for September 28, 2011: Fletcher Building (ASX:FBU) Announce Major Supply Contract for the Queensland Coal Seam Gas Market

newsroom@abnnewswire.net — Wed, 28 Sept 2011 12:02:16 GMT

Fletcher Building Limited (ASX:FBU) said today that Iplex Pipelines, which was recently acquired by Fletcher Building, has been awarded a A$120 million contract for the supply of polyethylene pipe to QGC Pty Limited ("QGC") for its Queensland Curtis Island LNG Project. This is a priority project of QGC, a British Gas Group business, to develop Queensland coal seam gas for Australian and international markets.

Integra Mining Limited (ASX:IGR) reported aircore drilling results from reconnaissance drilling in the Mt Monger area. Re-assay of the original samples returned 6 metres at 44.26 g/t gold including 4 metres at 65.40 g/t gold. Follow-up aircore drilling is in-progress to further define targets for deeper RC drilling.

African Iron Limited (ASX:AKI) provides an update on drilling activities at its 92%-owned Mayoko iron ore project in the Republic of Congo. Drilling capacity has now been increased comprising three reverse circulation and two diamond drill rigs. Interim JORC resource update is expected to be released by the end of October.

Alchemia Limited (ASX:ACL) said today that its leading cancer product HA-Irinotecan has received very promising trial results in a Phase II clinical study. Two lung cancer patients have experienced substantial shrinkage of their tumours after only ten days. The current study is examining the effectiveness of HA-Irinotecan, which utilises Alchemia's patented HyACT(R) technology. A Phase III study in colorectal cancer is expected to commence in 2011.

Tata Communications (BOM:500483) has become one of the few global carriers to extend its global IP/VPN service offerings into Pakistan, through a collaboration with Multinet Pakistan Private Limited. The collaboration now makes Tata Communications the largest global Ethernet provider in the world.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Asian Activities Report for July 28, 2011: Novogen Limited (ASX:NRT) Announce Results of Pre-Clinical Studies in Chemotherapy-Resistant Ovarian Cancer Stem Cells

newsroom@abnnewswire.net — Thu, 28 July 2011 12:02:50 GMT

Novogen Limited's (ASX:NRT) subsidiary, Marshall Edwards, Inc.(NASDAQ:MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced the publication of results from a pre-clinical study of NV-128. This study shows that NV-128 can induce cell death in chemotherapy-resistant ovarian cancer stem cells, providing encouraging data for further study in ovarian cancer.

Anatolia Energy Limited (ASX:AEK) announced an initial JORC Mineral Resource estimate of 17.4Mlb U3O8 for the Temrezli uranium prospect in Turkey. The resource estimate exceeds the exploration tonnage potential expected for the Temrezli deposit, and provides all necessary encouragement for the feasibility study on the establishment of a uranium production facility that can leach the ore in-situ and recover uranium from Temrezli and other deposits.

Waratah Resources Limited (ASX:WGO) has signed a binding Share Sale Agreement to acquire the Okanabora Project in the Republic of Congo. The Project is centred approximately 75 kms southwest of Waratah's existing Youkou project. Recent field work from the Okanabora Project returned results up to 60% Fe2O3. Waratah's immediate goal is to define a JORC inferred resource by Q1 2012 at Youkou and Q2 2012 at Okanabora 2012.

David Jones Limited (ASX:DJS) is launching a new brand campaign titled "WAS. IS. ALWAYS. DAVID JONES" for Spring/Summer 2011 to further enhance its position as the premier department store in Australia. To support the campaign, David Jones is introducing 60 exciting new brands and brand extensions into its business, the vast majority of which are department store exclusive to the Company.

Asia Business News
Sydney Tel: +61-2-9247-4344
Tokyo Tel: +81-3-6868-3802
http://www.abnnewswire.net

Asian Activities Report for June 8, 2011: Agenix (ASX:AGX) On Track To Begin Clinical Trials In China For The New Hepatitis B Drug

newsroom@abnnewswire.net — Wed, 8 June 2011 12:00:11 GMT

Major Asian markets all had a negative start in today's trading. The S&P/ASX200 lost 0.80% to 4529.9 in early trade. Nikkei 225 dropped 0.40% to 9,404.71. Hang Seng Index slid 0.99% to 22641.75, while Shanghai Composite was down 0.58% to 2728.44.

Companies

China-focused drug development and diagnostic company Agenix (ASX:AGX) said that the Company was on track to begin clinical trials in China for its lead Hepatitis B drug, AGX 1009. Agenix will file a formal application with China's State Food and Drug Administration in the second quarter of 2012 and anticipates approval to begin Phase I human studies in late 2012.

Central Asia Resources Limited (ASX:CVR) announced a substantial increase in the Indicated and Inferred Resources for its Dalabai Gold Project in the Republic of Kazakhstan. Total Indicated and Inferred Resources for Dalabai have increased 28% to 124,000 ounces of gold. Construction of the Dalabai mine remains on schedule for completion and start of production in Q4 2011.

Tanami Gold NL (ASX:TAM) announced a further substantial increase in its gold Mineral Resources to 2.30 million ounces of gold. Experienced mining engineer, Mr Don Harper, has been appointed as Tanami Gold's new Chief Operating Officer, to oversee the Company's target to lift production from Western Tanami and commence production at the Central Tanami Project by mid-2012.

Corazon Mining Limited (ASX:CZN) said today that initial assay results from the Lynn Lake nickel sulphide project in Canada confirmed the existence of a high-grade nickel/copper sulphide discovery. Drilling is currently at a depth of approximately 1,000 metres and will continue to 1,250 metres to test for further mineralisation in July.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Asian Activities Report for May 2, 2011: East Energy Resources (ASX:EER) Announce Maiden JORC Indicated Resource At Blackall Coal Project

newsroom@abnnewswire.net — Mon, 2 May 2011 12:00:45 GMT

East Energy Resources Limited (ASX:EER) announced a maiden JORC Indicated Resource of 469 million tonnes of thermal coal at its Blackall Coal Project in Central Queensland. The total Inferred and Indicated Resource is now estimated at 749 million tonnes, which is calculated based on an exploration area of about 15% of the Blackall tenement area. Mineralisation extends into the northern area of the project, where drilling is ongoing to further expand the project's tonnage.

Oilex Limited (ASX:OEX) advises that the La Rocca-1 well on the WA-388-P permit offshore Western Australia was spudded on 30 April 2011. The permit contains a portfolio of play types and seven prospects have been identified ranging in potential size from 0.3 to 2.8 trillion cubic feet of prospective gas resource. The La Rocca-1 well is the first exploration well drilled in the permit.

PT ANTAM (Persero) Tbk (ASX:ATM) said today that its income during the first quarter 2011 jumps 71% over the same period of 2010 to 346.6 billion Rupiah. Antam's earnings per share was 36.39 Rupiah for the first quarter of 2011 compared to 21.20 Rupiah of the same period last year. The significant increase was due to increased sales volume of ferronickel and higher commodity prices. Antam's net cash position remained strong to support its growth projects.

Canadian biopharmaceutical company Bioniche Life Sciences Inc. (TSE:BNC) (ASX:BNC) today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre in Canada. This expansion provides Bioniche with the capability to produce a wide spectrum of vaccines, with fermentation capabilities of up to 5,000 litres and all downstream processing and supporting utilities.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Asian Activities Report for April 6, 2011: Motopia Limited (ASX:MOT) Bolsters Business Wire Online Reach in Australia And New Zealand

newsroom@abnnewswire.net — Wed, 6 Apr 2011 12:00:56 GMT

Australia's mobile marketing solutions provider Motopia Limited (ASX:MOT) said today that its subsidiary cBox Pty Ltd has been appointed as Business Wire's Australasian media distribution partner. cBox is creating a network of guaranteed web posting sites and mobile delivery platforms to significantly expand Business Wire's online visibility in the Australia and New Zealand markets. Web sites that have already joined the online network are experiencing greater traffic, creating the potential for new revenue opportunities.

MACA Limited (ASX:MLD) has been awarded a 60 month contract by WPG Resources Limited (ASX:WPG) for the Peculiar Knob Iron Ore Project in South Australia. MACA will provide crushing and screening services as well as train loading operations. The contract will generate approximately A$127 million in revenue over a period of 5 years. Mobilisation is expected in the first calendar quarter of 2012.

Rey Resources Limited (ASX:REY) has upgraded the estimated resources at Duchess Paradise Thermal Coal Project in Western Australia to 305.8 million tonnes, a 9% increase over the 2009 estimate. The Company is on track to complete Definitive Feasibility Study of the Project by June 2011 and will commence a drilling program in the second quarter of 2011.

Circadian Technologies Limited (ASX:CIR) said today that its anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth and spread in a variety of different mouse models of human cancer including lung, ovarian and prostate cancer. Subject to the successful completion of the animal safety/toxicology studies, Circadian intends to file an Investigational New Drug application with the US Food And Drug Administration in the third quarter of 2011 in order to begin human clinical trials of VGX-100.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Australian Market Report of February 24, 2011: Viralytics (ASX:VLA) Receive Chinese Notice To Grant Patent Of Use Of EVATAK(TM) In Ovarian Cancer

newsroom@abnnewswire.net — Thu, 24 Feb 2011 12:10:55 GMT

Viralytics Limited (ASX:VLA) received a patent granting notice from China regarding the use of EVATAK(TM) as an anti-cancer agent in human ovarian cancer. The Company also has a Phase II Investigational New Drug application for late stage melanoma patients under discussion with the US Food and Drug Administration using its lead oncolytic virus, CAVATAK(TM). Two Phase I safety trials in Australia, studying the safety of both intratumoural and intravenous delivery of CAVATAK(TM) are currently underway.

Peak Resources Limited (ASX:PEK) reported the remaining assay results from the November-December 2010 RC and diamond drilling campaign in the central hills area at Ngualla. The Southern Rare Earth Zone has been further extended reporting results including 8m at 5.18% REO, 30.69m at 4.51% REO and 19m at 4.98% REO. Assay results from the northern niobium-tantalum zone have returned the highest grades of niobium, tantalum and phosphate encountered to date.

Ferrum Crescent Limited (ASX:FCR) has commenced a programme of reverse circulation and diamond core drilling at the Moonlight Iron Ore Project in South Africa. The drilling will provide additional geological understanding in important areas of the deposit and provide bulk sample for the first stage of an ongoing metallurgical testwork programme. Moonlight contains a JORC compliant resource of 74Mt in the Indicated Resource category and 225Mt in the Inferred Resource category. The Company anticipates an upgraded resource statement in Q2 2011.

United Uranium Limited (ASX:UUL) is pleased to announce that the No.1 Institute of Geology and Minerals of Shandong Province ("SDGM") has received formal approval from the Foreign Investment Review Board (FIRB) to subscribe for 5,600,000 shares in the Company at an issue price of 21 cents per share for total consideration of A$1,176,000. FIRB has also provided formal approval for SDGM to acquire up to 51% of the issued capital of the Company and up to a 50% interest in six tenements. United Uranium will work with SDGM to further advance these tenements in the Northern Territory.

Gindalbie Metals Limited (ASX:GBG) announced today that the maiden shipment of iron ore from the Karara Iron Ore Project in Western Australia will occur within two months, following the signing of a hematite ore sales agreement with Sinosteel Midwest Corporation. The agreement, for a total of 480,000 tonnes of high-grade direct shipping ore mined at Karara, marks the effective transition of the Project to production well ahead of the completion of project construction later this year.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Australian Market Report of February 21, 2011: Prima BioMed (ASX:PRR) To Commence Clinical Trial For Ovarian Cancer Immunotherapy Vaccine

newsroom@abnnewswire.net — Mon, 21 Feb 2011 12:21:54 GMT

Prima BioMed Limited (ASX:PRR) today announced that there has been an agreement for strategy and design of the Phrase III clinical trial for the CVac(TM) immunotherapy therapeutic ovarian cancer vaccine. The agreement comes after the European regulator, the European Medicines Agency advised that Scientific Advice for the Phase III trial had successfully been granted. Receiving Scientific Advice is a significant milestone in the timeline progression for CVac(TM)'s global registration. Prima can now move forward and begin preparations for patient enrolment into the trial. If the trial is successful, CVac(TM) will become the world's first ovarian cancer immunotherapy treatment.

Redstone Resources Limited (ASX:RDS) reported further significant assay results from recent reverse circulation drilling at its 100% owned Tollu copper project in Western Australia. Copper sulphide mineralisation has been extended to over 200m strike length and to a depth of 253m, highlighting the potential to increase the size of the mineralised body. Further drilling is scheduled to commence in May 2011 to extend the current mineralisations and test other Cu-rich areas.

Western Desert Resources Limited (ASX:WDR) today reported that assay results from drilling at its Roper Bar Iron Ore Project in the Northern Territory have identified further high grade direct shipping iron ore. Five holes recoded intersections with grades greater than 60% Fe. Iron ore mineralization extends over 1200 metres strike length. The Company will continue to assess the area's potential for commercial mining operations.

Canyon Resources Limited (ASX:CAY) has accelerated its exploration programme on its gold projects in Burkina Faso, following the discovery of several new prospects on its recently acquired permits. Since late November 2010, the Company has drilled 6,616 meters and taken over 1,300 samples with highest grades up to 6.16 g/t Au. The Company is to commence its maiden reverse circulation drill programme in late March or early April 2011.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

Australian Market Report of February 7, 2011: Automotive Technology Group (ASX:ATJ) Announce Most Efficient Supercharger System In The World

newsroom@abnnewswire.net — Mon, 7 Feb 2011 13:30:00 GMT

Automotive Technology Group Limited (ASX:ATJ) announced that the latest testing program has confirmed that the Company's patented low emissions, high fuel efficiency Sprintex (R) Supercharger is the world's most efficient automotive supercharger system. The Sprintex (R) Series 5 Supercharger recorded a peak isentropic efficiency of 83.89%, higher than a typical automotive supercharger which has isentropic efficiency of less than 70%. Improved efficiency allows vehicle manufacturers to build supercharged engines without the need for intercooling. This delivers smaller engine packages at a lower cost and results in a significant increase in overall vehicle energy efficiency.

Aviva Corporation Limited (ASX:AVA) announced that a coal study has confirmed that export grade thermal coal can be produced from the Company's Mmamantswe project in Botswana. The study demonstrates that the 895Mt Mmamantswe project could yield 200Mt of export grade thermal coal and an additional 100-150Mt of domestic power coal capable of supporting a 300MW domestic power station. The project could produce 3Mtpa of export thermal coal and 1-1.5Mtpa of domestic power coal with sufficient reserves for over 60 years.

EnviroGold Limited (ASX:EVG) has significantly strengthened its management by the appointment of Mr Oscar Alvarado as Regional Director for its operations in Latin America. Mr Alvarado's initial responsibilities will be focused on achieving an annual production rate of 65,000 oz of gold and 600,000 oz of silver at the Company's Las Lagunas gold project in the Dominican Republic from the end of 2011, and subsequently, driving the expansion of the Pinglio and Papercorp gold mines in Ecuador to achieve 100,000 oz gold per year by end 2013.

Phosphagenics Limited (ASX:POH) (PINK:PPGNY) has entered into an agreement with a US private dermatology company to develop a prescription drug to treat psoriasis. The collaborator has received approval from the US Food and Drug Administration for an Investigational New Drug application clearing the path to commence a Phase 1 clinical study in the US. The collaborator will also pay for Phase 1 study to begin before July.

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net